Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/62900
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSuryawanshi, M R-
dc.contributor.authorRane, R A-
dc.contributor.authorBabhulkar, G V-
dc.contributor.authorKhobragade, P D-
dc.contributor.authorMoharir, S R-
dc.contributor.authorChindhe, S A-
dc.contributor.authorPawar, D K-
dc.date.accessioned2023-11-17T05:57:24Z-
dc.date.available2023-11-17T05:57:24Z-
dc.date.issued2023-11-
dc.identifier.issn2583-1321 (Online); 0019-5103 (Print)-
dc.identifier.urihttp://nopr.niscpr.res.in/handle/123456789/62900-
dc.description1201-1207en_US
dc.description.abstractThis research work describes a highly efficient route for the synthesis and characterization of the two potential sumatriptan impurities, N-hydroxymethyl sumatriptan (Impurity C) and sumatriptan dimer (Impurity H). The purity of the synthesized impurities have been confirmed using HPLC, and their structures have been identified by using MS and ¹H NMR spectroscopy.en_US
dc.language.isoenen_US
dc.publisherNIScPR-CSIR,Indiaen_US
dc.sourceIJC Vol.62(11) [November 2023]en_US
dc.subjectImpuritiesen_US
dc.subjectHPLCen_US
dc.subjectNMRen_US
dc.subjectMigraineen_US
dc.titleA highly efficient route for synthesis of N-hydroxymethyl sumatriptan and sumatriptan dimer: Impurity C and H of anti-migraine drug sumatriptanen_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.56042/ijc.v62i11.5015en_US
Appears in Collections:IJC Vol.62(11) [November 2023]

Files in This Item:
File Description SizeFormat 
IJC 62(11) 1201-1207.pdf745.8 kBAdobe PDFView/Open
IJC 62(11) 1201-1207_Suppl. Data.pdf1.11 MBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.